Virtu Financial’s Centessa Pharmaceuticals CNTA Stock Holding History

Virtu Financial’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-67,775	Closed	-$2.69M	–	1695
2026 Q1	$2.69M	Buy	+67,775	New	+$1.73M	0.11%	112

Virtu Financial's CNTA Position: Q2 2026 in Review

Virtu Financial sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 67,775 shares — an estimated $2.69M sold.

Virtu Financial first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $2.69M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Virtu Financial reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Virtu Financial sold 67,775 Centessa Pharmaceuticals shares in Q2 2026, an estimated $2.69M.
Virtu Financial first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Virtu Financial's Centessa Pharmaceuticals position peaked at $2.69M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.